BAX: Baxter International Inc. Kompaniya qiymatining sof foydaga nisbati

Baxter Healthcare - BAX emitenti grafik logotipi

Baxter International (BAX) ishlab chiqarishida ESG standartlarining joriy etilishi va plastikni qayta ishlash kompaniyaning P/E koeffitsiyenti o'zgarishlari bilan bog'liq bo'lib, bunda -19.10 joriy parametr qiymati vazifasini bajaradi. Qat'iy sterillik talablari va uzoq muddatli shartnomalar raqobatchilar uchun mustahkam kirish to'siqlarini yaratadi. Biroq, sezilarli qarzlar va inflyatsion xarajatlar biznes uchun asosiy xavf omillari bo'lib qolmoqda.

Baxter International Inc. (BAX) Narxning foydaga nisbati: 04.07.2022 - 10.11.2026 davri uchun

Baxter Corp (BAX) kompaniyasining tahliliy kesimlari

- kotirovkalar va tahlilchilar prognozi:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning har tomonlama tahlili:baxter.com - BAX
Baxter International Inc. ishlab chiqargan mahsulot

Portfel menejeri sifatida men ushbu ko'rsatkichni bir dollar foyda narxini baholash vositasi deb hisoblayman. Ushbu metrika investitsiyalarning qoplanish muddatini va aktivlarning haddan tashqari qiziganlik darajasini aniqlash uchun bozor kapitalizatsiyasini sof foyda bilan solishtiradi. P/E koeffitsiyentini tahlil qilish orqali investor past baholangan davrda kirish nuqtasini aniqlashi mumkin. Baxter International (BAX) uchun bu holat sarf materiallariga bo'lgan barqaror talab bilan qo'llab-quvvatlanadi, bu esa biznesni qayta qurish xarajatlarini qoplaydi.

Raqobatdosh kompaniyalar

Narxning foydaga nisbati ISRG|Narx-foyda koeffitsiyenti DHR (Danaher)|BDX (BD) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori STE (STERIS Corporation)|Biznesning o‘zini qoplash muddati West Pharma Corp (WST)|MASI - Narxning foydaga nisbati|STVN (stevanatogroup.com) - Narx-foyda multiplikatori|Teleflex (TFX) - Narxning foydaga nisbati|MMSI - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti NVST|ICUI (ICU Medical Inc.) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati DENTSPLY SIRONA Inc. (XRAY)|LMAT (lemaitre.com) - Kompaniya qiymatining sof foydaga nisbati|AtriCure - Narx-foyda koeffitsiyenti|P/E multiplikatori STAAR Surgical Co. STAA|NAGE - Narxning foydaga nisbati|ZimVie Corp (ZIMV) - Narx-foyda koeffitsiyenti|ANGO: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati cerus.com (CERS)|Narxning foydaga nisbati Teknova|Narx-foyda multiplikatori MGRM (Monogram Technologies Inc.)|Narx-foyda koeffitsiyenti STSS (Sharps Technology, Inc.)|Bozor narxining sof foydaga nisbati INFU|Narxning foydaga nisbati Utah Medical Products UTMD|Biznesning o‘zini qoplash muddati KORU Medical Systems, Inc. (KRMD)|Nyxoah - P/E multiplikatori|MBOT: Narxning foydaga nisbati|PDEX: P/E multiplikatori|Zentek Corp (ZTEK) - P/E multiplikatori|Narx-foyda koeffitsiyenti ELUT|Narx-foyda multiplikatori MLSS (milestonescientific.com)|Narx-foyda koeffitsiyenti NXGL (NEXGEL)|Bozor narxining sof foydaga nisbati RVP|P/E multiplikatori HBIO (Harvard Bioscience)|Femasys Corporation (FEMY) - Kapitalizatsiyaning foydaga nisbati|MHUA - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati POAI (Predictive Oncology)|CJMB (callanjmb.com) - Narx-foyda koeffitsiyenti|Atrion Corp. - Kompaniya qiymatining sof foydaga nisbati|NURO (NeuroMetrix Corp) - P/E multiplikatori